High-Throughput Ex Vivo Drug Sensitivity and Resistance Testing (DSRT) Integrated with Deep Genomic and Molecular Profiling Reveal New Therapy Options with Targeted Drugs in Subgroups of Relapsed Chemorefractory AML

Caroline A. Heckman, Mika Kontro, Tea Pemovska, Samuli Eldfors, Henrik Edgren, Evgeny Kulesskiy, Muntasir Mamun Majumder, Riikka Karjalainen, Bhagwan Yadav, Agnieszka Szwajda, Naga Poojitha Kota Venkata, Astrid Murumagi, Disha Malani, Alun Parsons, Petteri Hintsanen, Henrikki Almusa, Jesus Maria Lopez Marti, Pekka Ellonen, Pirkko Mattila, Maija LepistoSonja Lagstrom, Minna Suvela, Satu Mustjoki, Janna Saarela, Tero Aittokallio, Olli Kallioniemi, Krister Wennerberg, Kimmo Porkka

Research output: Contribution to journalMeeting AbstractResearchpeer-review

Original languageEnglish
Article numberMeeting Abstract: 288
JournalBlood
Volume120
Issue number21
Number of pages2
ISSN0006-4971
Publication statusPublished - 16 Nov 2012
Event54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - Atlanta, Gabon
Duration: 8 Dec 201211 Dec 2012

Cite this